FIJ -62.5% SP Drop since Quarterly Report: What's Changed?

What's changed since the quarterly report?
.

• Zane Yoshida has left the helm, replaced temporarily by Nicholas Simms before a firm replacement is found 2021
• Nicholas Simms has opted to receive 1M in oppies as payment for this period of work as CEO, with note that if they weren't granted at AGM, he would receive equal amount in cash regardless of the vote (what he earns in this period is dependant on healthy stock price)
• Q12021FY quarter reported revenue of a mere $164,249 (a decrease of 55% q/q)
• 2 days after quarterly period ended, on October 2nd FIJ received $117,185 in revenue
• Both supply issues due to freight interruptions in Fiji were disclosed, and within internal processes, casting doubt over management/lack of communication
• MOU signed with Yuan Long Yoto, a leading Chinese online/direct network company.
• Chinese pressure on Australia companies/imports (Shouldn't effect FIJ given extremely strong ties between China and Pacific Islands - FIJ help the Fijian community and economy, it would be one of the last things pressured)

.
What has changed since the last time we were at 12c per share? (let alone 10.5c)

• $4.4M in cash raised at 18c per share, representing a premium of 71% to today's prices. It was oversubscribed 4x, with $12M in bids (almost in todays market cap, FIJ recieved bids for shares at 18c)
• $8M deal with Chinese company PuMate, with Charles Li at the helm, which is Nicholas Simms old business partner and Chinese CEO from Bubs
• Blackmores supply agreement signed for their clinical bioceuticals product, Anxiocalm.
• The Australian government to spend $1.9M of the recent budget for Kava to be commercially imported to Australia in late 2021 in traditional and powder forms, for all uses (not just therapeutic).
• CODEX reclassification of Kava from a drug to a food.

.
Conclusion & Question to holders:
.We now have $4.4M in cash, plus the major cornerstone contracts, with regulations in multiple districts falling in Kava's favour, and we have an MOU with a leading Chinese online/direct network company, yet we are currently trading at a 20% discount to the last time we traded at these prices, when we had none of these contracts or regulatory windfalls, and only had $700k cash. The last $4.4M was raised at a 71% premium to todays prices. Question: is this fall in SP justified? Or is this an overreaction?

Interested to know your thoughts. GLTAH, not financial advice, please DYOR.